Navigation Links
Abveris and Geneious Biologics Collaborate to Advance Antibody NGS Data Analysis
Date:6/11/2019

With a rapidly growing customer base and a wide range of antibody discovery services, Abveris plans to leverage the Geneious Biologics platform as a premium hub for bioinformatics and computer programming capabilities.

Dr. Colby Souders, Chief Technology Officer at Abveris, says: “The Geneious team has done an excellent job accommodating our specific data, resulting in a streamlined, high-throughput workflow that produces accurate data and operates efficiently without the need to integrate multiple bioinformatics platforms. We look forward to continuously improving the platform and its integration into our workflow to combine sequence analytics with metadata and assay data to accelerate candidate selection.”

The Geneious team worked closely with Abveris to optimize and enhance the handling of their antibody NGS data. Jannick Bendtsen, VP Technology Services at Geneious, says: “Abveris is at the cutting edge of antibody drug discovery; they are pushing the boundaries of science and technology. To have Colby and the team select Geneious Biologics is a great honor and a great compliment. We collaborated to integrate our Single Clone Antibody Annotator Pipeline and it now runs out of the box. It’s all about speed and accuracy in the discovery process.”

About Abveris
Abveris is a premium Boston-area contract research organization specializing in antibody discovery. Abveris partners with large and small biopharmaceutical companies to discover novel therapeutic products and critical reagent antibodies using diverse platforms, including the proprietary DiversimAb™ hyperimmune mouse technology and a variety of humanized mice. Additional information about Abveris is available at http://www.abveris.com.

About Geneious and Biomatters
Biomatters empowers its customers with software that transforms biological data into knowledge and actionable insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering and advanced comparative analysis of DNA, RNA and protein sequences. Geneious solutions are created from a deep understanding of customer experience and turn the difficult into the intuitive and easy. That is why Geneious is trusted by over 4,000 companies, universities and institutes all over the globe. http://www.geneious.com

Read the full story at https://www.prweb.com/releases/abveris_and_geneious_biologics_collaborate_to_advance_antibody_ngs_data_analysis/prweb16370725.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Geneious Supports the Transition from Vector NTI
2. Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019
3. 3Bar Biologics and Pivot Bio Help Farmers Increase Crop Productivity and Decrease Need for Fertilizer
4. Royal Biologics Launches Maxx-Cell, the World's Most Advanced Bone Marrow Aspiration Device
5. Dovel Technologies Awarded Biologics Surveillance IDIQ
6. Genedata Announces Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D
7. AcCELLerated Biologics announces strategic partnership with Exceleron Media.
8. Mosaic Biomedicals se une a Northern Biologics
9. Synthetic Biologics Announces Pricing of Public Offering of Common Stock and Warrants
10. Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025
11. MassBiologics receives orphan drug status from FDA for hepatitis C treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... ... May 22, 2019 , ... Leak Detection Associates (LDA), ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to ... (IPP) Ltd has been signed. The agreement will grant exclusive rights for ...
(Date:5/21/2019)... ... , ... Suvoda LLC , a SaaS provider of Interactive Response Technology ... of Inc. Magazine’s Best Workplaces for 2019, Inc.’s fourth annual ranking of the fast-growing ... hitting the newsstands on May 28, is the result of a comprehensive measurement of ...
(Date:5/21/2019)... ... 20, 2019 , ... The ASGCT Clinical Trials Finder is a ... the United States. Data curated daily from ClinicalTrials.gov ensures the most up-to-date and applicable ... volunteered to assist in the development of the ASGCT Clinical Trials Finder ...
Breaking Biology News(10 mins):
(Date:5/4/2019)... PINE BROOK, N.J. (PRWEB) , ... May 03, ... ... visual electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response ... signs of glaucoma. , By 2050, it is estimated that 6.3 million Americans ...
(Date:5/2/2019)... ... 02, 2019 , ... Researchers from Ambry Genetics ... U.S. insurer policies for genetic testing and the 2019 National Comprehensive Cancer Network ... cancer (HBOC). , Jill S. Dolinsky, director of clinical affairs at ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... research team that includes a chemical engineer at Worcester Polytechnic Institute (WPI) has ... may make it possible to manufacture isobutanol and other biofuels more economically. , ...
(Date:4/12/2019)... ... April 12, 2019 , ... An upcoming episode of Advancements ... innovative tools and devices being used to enhance cognitive skills. This episode is ... segment of Advancements will focus on Sound for Life, a neurotechnology company helping ...
Breaking Biology Technology: